Members of the ETS-family of transcription factors are downstream effectors of FGF-signalling during embryonic development31–33 but their role in urothelial carcinomas driven by FGFR3 mutation has not been investigated so far. This evidence concerns the gene FGFR3 and urothelial carcinoma.